Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Change in Acquisitions & Divestments (2023 - 2024)

Milestone Scientific (MLSS) has disclosed Change in Acquisitions & Divestments for 2 consecutive years, with $972110.0 as the latest value for Q2 2024.

  • Quarterly Change in Acquisitions & Divestments changed N/A to $972110.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $972110.0 through Mar 2025, down 86.05% year-over-year, with the annual reading at $3.0 million for FY2024, 40.06% down from the prior year.
  • Change in Acquisitions & Divestments hit $972110.0 in Q2 2024 for Milestone Scientific, down from $2.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $4.5 million in Q3 2023 to a low of $493673.0 in Q4 2023.